Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

McGill University

$24,000.00

Development of a cement with cells embedded in alginate to reconstruct large osseous defects

EF 2006-07

Résumé
5% of infants born in North America have birth defects, and three-quarters of these involve the craniofacial complex (head, face, and oral tissues). There are hundreds of disorders affecting the face, skull, jaws, and teeth. The cleft lip with or without cleft palate is the most common one (1:1000 births). Craniofacial defects may also result from tumor resection and from trauma. The social and economic costs of these craniofacial disorders and defects are enormous and they create a high burden on particular groups in the population. The loss of hard tissues (bone or cartilage) due to these craniofacial defects represents serious problems in head and neck surgery. Rehabilitation treatments available for these patients are autologous bone grafts, allografts, and synthetic bone grafts. Synthetic cements such as the calcium phosphate-based cements are of particular interest to treat craniofacial defects because they can be contoured to the shape of the defects to be repaired. However for large osseous defects (such as those seen in resections due to head and neck cancer, osteoradionecrosis, or cleft palates), no use of biomaterial alone or combinations of biomaterials can regenerate fully these lost tissues. We propose to test a new generation of "cell-based hybrid biomaterial" that can deliver progenitor cells to specific craniofacial defects and diseases. Our proposed biomaterial consists of 3 main components: 1) autologous mesenchymal progenitor cells (isolated from extracted teeth) which are encapsulated into 2) alginate and seeded into 3) calcium phosphate cements.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
327846-2006
Name nom
Tran, Simon
Department département
Dentistry, Faculty of
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2006
Competition year année de concours
2006
Award amount
24000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
4
Committee name en
Chem. & Metallurgical Eng.
Committee name fr
Génies chimique et métal.
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
4
Application title
Development of a cement with cells embedded in alginate to reconstruct large osseous defects
Keyword
NA
Application summary
5% of infants born in North America have birth defects, and three-quarters of these involve the craniofacial complex (head, face, and oral tissues). There are hundreds of disorders affecting the face, skull, jaws, and teeth. The cleft lip with or without cleft palate is the most common one (1:1000 births). Craniofacial defects may also result from tumor resection and from trauma. The social and economic costs of these craniofacial disorders and defects are enormous and they create a high burden on particular groups in the population. The loss of hard tissues (bone or cartilage) due to these craniofacial defects represents serious problems in head and neck surgery. Rehabilitation treatments available for these patients are autologous bone grafts, allografts, and synthetic bone grafts. Synthetic cements such as the calcium phosphate-based cements are of particular interest to treat craniofacial defects because they can be contoured to the shape of the defects to be repaired. However for large osseous defects (such as those seen in resections due to head and neck cancer, osteoradionecrosis, or cleft palates), no use of biomaterial alone or combinations of biomaterials can regenerate fully these lost tissues. We propose to test a new generation of "cell-based hybrid biomaterial" that can deliver progenitor cells to specific craniofacial defects and diseases. Our proposed biomaterial consists of 3 main components: 1) autologous mesenchymal progenitor cells (isolated from extracted teeth) which are encapsulated into 2) alginate and seeded into 3) calcium phosphate cements.